Does PALBOCICLIB Cause Hypersensitivity? 417 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 417 reports of Hypersensitivity have been filed in association with PALBOCICLIB (Ibrance). This represents 0.5% of all adverse event reports for PALBOCICLIB.
417
Reports of Hypersensitivity with PALBOCICLIB
0.5%
of all PALBOCICLIB reports
12
Deaths
57
Hospitalizations
How Dangerous Is Hypersensitivity From PALBOCICLIB?
Of the 417 reports, 12 (2.9%) resulted in death, 57 (13.7%) required hospitalization, and 5 (1.2%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 417 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which PALBOCICLIB Alternatives Have Lower Hypersensitivity Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID